Search research articles
Contact Us
Filters
Showing results (441-450 of 903) with videos related to
Page
of 91
Sort By:
Clinical Chemistry
|
December 7, 2017
Unbiased Approach to Counteract Upward Drift in Cerebrospinal Fluid Amyloid-β 1-42 Analysis Results
Betty M Tijms, Eline A J Willemse, Marissa D Zwan, et al.
Dementia and Geriatric Cognitive Disorders
|
November 13, 2010
How useful is the IQCODE for discriminating between Alzheimer's disease, mild cognitive impairment and subjective memory complaints?
Sietske A M Sikkes, Mark T van den Berg, Dirk L Knol, et al.
Radiology
|
December 15, 2012
Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity
Maja A A Binnewijzend, Joost P A Kuijer, Marije R Benedictus, et al.
Journal of the International Neuropsychological Society : JINS
|
August 14, 2012
An informant questionnaire for detecting Alzheimer's disease: are some items better than others?
Sietske A M Sikkes, Dirk L Knol, Mark T van den Berg, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 15, 2010
Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET images
Nelleke Tolboom, Wiesje M van der Flier, Jolanda Boverhoff, et al.
Alzheimer Disease and Associated Disorders
|
August 5, 2010
Dementia mimicking Alzheimer's disease Owing to a tau mutation: CSF and PET findings
Nelleke Tolboom, Esther L G E Koedam, Jonathan M Schott, et al.
Neurology
|
February 13, 2018
Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab
Enchi Liu, Dai Wang, Reisa Sperling, et al.
Frontiers in Aging Neuroscience
|
October 24, 2017
Corrigendum: White Matter Changes-Related Gait and Executive Function Deficits: Associations with Age and Parkinson's Disease
Jennifer Sartor, Kristina Bettecken, Felix P Bernhard, et al.
Frontiers in Aging Neuroscience
|
July 18, 2017
White Matter Changes-Related Gait and Executive Function Deficits: Associations with Age and Parkinson's Disease
Jennifer Sartor, Kristina Bettecken, Felix P Bernhard, et al.
Alzheimer'S Research & Therapy
|
September 13, 2019
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
Arno de Wilde, Juhan Reimand, Charlotte E Teunissen, et al.
Page
of 91
Search research articles
Search
Showing results (441-450 of 903) with videos related to
Sort By:
Page
of 91
Clinical Chemistry
|
December 7, 2017
Unbiased Approach to Counteract Upward Drift in Cerebrospinal Fluid Amyloid-β 1-42 Analysis Results
Betty M Tijms, Eline A J Willemse, Marissa D Zwan, et al.
Dementia and Geriatric Cognitive Disorders
|
November 13, 2010
How useful is the IQCODE for discriminating between Alzheimer's disease, mild cognitive impairment and subjective memory complaints?
Sietske A M Sikkes, Mark T van den Berg, Dirk L Knol, et al.
Radiology
|
December 15, 2012
Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity
Maja A A Binnewijzend, Joost P A Kuijer, Marije R Benedictus, et al.
Journal of the International Neuropsychological Society : JINS
|
August 14, 2012
An informant questionnaire for detecting Alzheimer's disease: are some items better than others?
Sietske A M Sikkes, Dirk L Knol, Mark T van den Berg, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 15, 2010
Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET images
Nelleke Tolboom, Wiesje M van der Flier, Jolanda Boverhoff, et al.
Alzheimer Disease and Associated Disorders
|
August 5, 2010
Dementia mimicking Alzheimer's disease Owing to a tau mutation: CSF and PET findings
Nelleke Tolboom, Esther L G E Koedam, Jonathan M Schott, et al.
Neurology
|
February 13, 2018
Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab
Enchi Liu, Dai Wang, Reisa Sperling, et al.
Frontiers in Aging Neuroscience
|
October 24, 2017
Corrigendum: White Matter Changes-Related Gait and Executive Function Deficits: Associations with Age and Parkinson's Disease
Jennifer Sartor, Kristina Bettecken, Felix P Bernhard, et al.
Frontiers in Aging Neuroscience
|
July 18, 2017
White Matter Changes-Related Gait and Executive Function Deficits: Associations with Age and Parkinson's Disease
Jennifer Sartor, Kristina Bettecken, Felix P Bernhard, et al.
Alzheimer'S Research & Therapy
|
September 13, 2019
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
Arno de Wilde, Juhan Reimand, Charlotte E Teunissen, et al.
Page
of 91